Nutriband, Inc. (NTRB)
5.71
-0.39
(-6.39%)
USD |
NASDAQ |
Sep 09, 15:46
Nutriband Total Assets (Quarterly) : 6.293M for July 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 6.293M |
| April 30, 2026 | 6.892M |
| January 31, 2026 | 7.548M |
| October 31, 2025 | 8.419M |
| July 31, 2025 | 10.18M |
| April 30, 2025 | 6.152M |
| January 31, 2025 | 7.47M |
| October 31, 2024 | 12.54M |
| July 31, 2024 | 13.63M |
| April 30, 2024 | 15.15M |
| January 31, 2024 | 7.517M |
| October 31, 2023 | 8.523M |
| July 31, 2023 | 9.873M |
| April 30, 2023 | 8.676M |
| January 31, 2023 | 9.456M |
| October 31, 2022 | 10.67M |
| July 31, 2022 | 11.39M |
| April 30, 2022 | 11.98M |
| January 31, 2022 | 12.74M |
| October 31, 2021 | 15.43M |
| July 31, 2021 | 10.16M |
| April 30, 2021 | 10.56M |
| Date | Value |
|---|---|
| January 31, 2021 | 9.927M |
| October 31, 2020 | 10.08M |
| July 31, 2020 | 2.199M |
| April 30, 2020 | 2.198M |
| January 31, 2020 | 2.198M |
| October 31, 2019 | 2.441M |
| July 31, 2019 | 2.353M |
| April 30, 2019 | 2.519M |
| January 31, 2019 | 2.808M |
| October 31, 2018 | 2.622M |
| July 31, 2018 | 3.071M |
| April 30, 2018 | 0.1109M |
| January 31, 2018 | 0.1649M |
| October 31, 2017 | 2.418M |
| July 31, 2017 | 2.508M |
| April 30, 2017 | 0.0097M |
| January 31, 2017 | 0.0377M |
| October 31, 2016 | 0.0171M |
| July 31, 2016 | 0.0345M |
| April 30, 2016 | 0.0612M |
| January 31, 2016 | 0.0003M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.9644M |
| Shareholders Equity (Quarterly) | 5.329M |
| Debt to Equity Ratio | 0.0412 |
| Current Ratio | 4.211 |
| Net Debt Paydown Yield | 0.04% |